Don't buy INDRAMEDCO now, it is underperforming the market
20 Jan, 20265 min read
INDRAPRASTHA MEDICAL CORP underperformed on Tuesday. It fell by -3.56% to close at 385.75. On a day when the overall market breadth was 35%, it closed higher than 70% of the market. In comparison, the benchmark NIFTY-50 index closed today at -0.0138%.